Fusion Pharmaceuticals Inc.

NASDAQ:FUSN

21.55 (USD) • At close June 4, 2024
Bedrijfsnaam Fusion Pharmaceuticals Inc.
Symbool FUSN
Munteenheid USD
Prijs 21.55
Beurswaarde 1,833,043,000
Dividendpercentage 0%
52-weken bereik 2.31 - 21.6
Industrie Biotechnology
Sector Healthcare
CEO Dr. John F. Valliant Ph.D.
Website https://fusionpharma.com

An error occurred while fetching data.

Over Fusion Pharmaceuticals Inc.

Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order to selectively deliver the alpha particle

Vergelijkbare Aandelen

Beyond Air, Inc. logo

Beyond Air, Inc.

XAIR

0.41 USD

Profound Medical Corp. logo

Profound Medical Corp.

PROF

8.2 USD

Talkspace, Inc. logo

Talkspace, Inc.

TALK

1.79 USD

Rhythm Pharmaceuticals, Inc. logo

Rhythm Pharmaceuticals, Inc.

RYTM

49.25 USD

Aldeyra Therapeutics, Inc. logo

Aldeyra Therapeutics, Inc.

ALDX

6.13 USD

Mainz Biomed B.V. logo

Mainz Biomed B.V.

MYNZ

0.327 USD

XBiotech Inc. logo

XBiotech Inc.

XBIT

6.52 USD

CymaBay Therapeutics, Inc. logo

CymaBay Therapeutics, Inc.

CBAY

32.48 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)